HAG
HighPoint Advisor Group Portfolio holdings
AUM
$1.88B
This Quarter Return
-13.89%
1 Year Return
+26.16%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$914M
AUM Growth
–
Cap. Flow
+$914M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
31.7%
Holding
541
New
541
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$85.7M |
| 2 |
Microsoft
MSFT
|
$45.1M |
| 3 |
Tesla
TSLA
|
$26.5M |
| 4 |
Amazon
AMZN
|
$26.3M |
| 5 |
AbbVie
ABBV
|
$25.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 24.76% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 14.22% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Consumer Staples | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRNE
501
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $51K | 0.01% |
+20,035
| New | +$51K |
|
|
BCLI
502
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $45K | ﹤0.01% |
+17,033
| New | +$45K |
|
503
Workhorse Group
WKHS
$19.8M
| $41K | ﹤0.01% |
+15,013
| New | +$41K |
|
504
Inseego
INSG
$195M
| $38K | ﹤0.01% |
+19,370
| New | +$38K |
|
505
Banco Santander
SAN
$140B
| $33K | ﹤0.01% |
+12,790
| New | +$33K |
|
506
Compugen
CGEN
$133M
| $32K | ﹤0.01% |
+15,149
| New | +$32K |
|
507
NRX Pharmaceuticals
NRXP
$62.5M
| $24K | ﹤0.01% |
+43,501
| New | +$24K |
|
508
Check-Cap
CHEK
$3.86M
| $22K | ﹤0.01% |
+64,000
| New | +$22K |
|
|
PRTK
509
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $22K | ﹤0.01% |
+10,242
| New | +$22K |
|
|
ETRM
510
DELISTED
EnteroMedics Inc.
ETRM
| $21K | ﹤0.01% |
+37,067
| New | +$21K |
|
|
FNM
511
DELISTED
FANNIE MAE
FNM
| $9K | ﹤0.01% |
+19,352
| New | +$9K |
|
512
iBio
IBIO
$16.1M
| $7K | ﹤0.01% |
+25,985
| New | +$7K |
|
513
Cemtrex
CETX
$6.3M
| $4K | ﹤0.01% |
+14,000
| New | +$4K |
|
|
ENDO
514
DELISTED
Endocare, Inc. NEW Common Stock
ENDO
| $0 | ﹤0.01% |
+12,000
| New | – |
|